Nagourney Cancer Blog

For Patients with the Most Advanced Lung Cancers: “Nunquam Cede” (Latin-Never Yield)

Dr. Robert A. Nagourney, MD

Dec 113 min read

For Patients with the Most Advanced Lung Cancers: “Nunquam Cede” (Latin-Never Yield)

I’ve long held that there are no bad cancers, just cancers that we can or cannot treat.

Why Do Chemotherapy Drugs Work For Some Cancer Patients and Not For Others?

Dr. Robert A. Nagourney, MD

Nov 193 min read

Breast Cancer

Why Do Chemotherapy Drugs Work For Some Cancer Patients and Not For Others?

Treatments should really be given more selectively, i.e. “give this chemotherapy only to those people who will benefit from it,” She said.

Metastatic Breast Cancer Claims Another Life

Dr. Robert A. Nagourney, MD

Sep 262 min read

Nagourney Cancer Blog

Metastatic Breast Cancer Claims Another Life

I received a video from an episode of Americas Got Talent, the popular TV program that features up-and-coming performers.

Stage 4 Cancer Patients Need Answers Not Questions: Genomic Variants Of Uncertain Significance (VUS) Don’t Help!

Dr. Robert A. Nagourney, MD

Sep 53 min read

Nagourney Cancer Blog

Stage 4 Cancer Patients Need Answers Not Questions: Genomic Variants Of Uncertain Significance (VUS) Don’t Help!

Genomic findings are a first step. They find targets. The question the patient wants to answer is “Can I hit the target?”

Metastatic or Recurrent Cancer Patients Can’t Afford to Guess

Dr. Robert A. Nagourney, MD

Jul 183 min read

Nagourney Cancer Blog

Metastatic or Recurrent Cancer Patients Can’t Afford to Guess

Cancer patients deserve better. Every patient is unique. Their treatment should be as well.

For Pancreatic Cancer Patients, “the More You Explain It, The More I Don’t Understand It.” -Mark Twain

Dr. Robert A. Nagourney, MD

Jun 132 min read

Pancreatic Cancer

For Pancreatic Cancer Patients, “the More You Explain It, The More I Don’t Understand It.” -Mark Twain

Even here in the potentially curable pancreatic cancer patients, there is a great deal of disagreement on the best treatment.

The Evolving Landscape of Pancreatic Cancer

Dr. Robert A. Nagourney, MD

Apr 292 min read

Nagourney Cancer Blog

The Evolving Landscape of Pancreatic Cancer

Nagourney Cancer Institute remains committed to pioneering research and that promise real hope for those affected by pancreatic cancer.

A Ray of Hope in the Fight Against Stage 4 Colon Cancer

Dr. Robert A. Nagourney, MD

Apr 23 min read

Cancer Survivor Stories

A Ray of Hope in the Fight Against Stage 4 Colon Cancer

Daniel Werner, a dedicated nurse and a loving fiancé and father, faced the grim reality of a stage 4 colon cancer diagnosis in December 2021

What’s a Pancreatic Cancer Doctor to do? More Importantly: What are Their Patients to do?

Dr. Robert A. Nagourney, MD

Mar 122 min read

Nagourney Cancer Blog

What’s a Pancreatic Cancer Doctor to do? More Importantly: What are Their Patients to do?

Screening for Pancreatic cancer, even in the highest-risk individuals found not cost effective.

Breakthrough in Pancreatic Cancer: New Blood Test for Early Detection, Could Offer Improved Therapy

Dr. Robert A. Nagourney, MD

Mar 42 min read

Nagourney Cancer Blog

Breakthrough in Pancreatic Cancer: New Blood Test for Early Detection, Could Offer Improved Therapy

Blood test results offer a “cancer signature” that distinguishes patients with pancreatic cancer from normal individuals.

Much Heralded New Treatment For Pancreatic Cancer Approved by FDA: But Has it Moved The Dial?

Dr. Robert A. Nagourney, MD

Feb 212 min read

Nagourney Cancer Blog

Much Heralded New Treatment For Pancreatic Cancer Approved by FDA: But Has it Moved The Dial?

The NAPOLI-3 trail trial median survival of 11.1 months is exactly the same as the original FOLFIRINOX regimen from 13 years ago.

Functional Profiling for Cancer is Scientifically Validated by Peer-Review

Dr. Robert A. Nagourney, MD

Feb 92 min read

Functional Profiling

Functional Profiling for Cancer is Scientifically Validated by Peer-Review

One of the critical advantages of Functional Profiling over traditional genomic testing is its focus on the actual response of cancer cells.

2 3 4 5

All Posts 260 postsNo categories yet.
Breast Cancer 22 postsNo categories yet.
Cancer Research 28 postsNo categories yet.
Functional Profiling 22 postsNo categories yet.
Advanced Cancer Research 33 postsNo categories yet.
Cancer Cells 17 postsNo categories yet.
Cancer Survivor Stories 45 postsNo categories yet.
Nagourney Cancer Blog 218 postsNo categories yet.
Lung Cancer 4 postsNo categories yet.
Pancreatic Cancer 5 postsNo categories yet.
Cancer Blood Test 1 postNo categories yet.
EVA/PCD 1 postNo categories yet.

Nagourney Cancer Blog

Subscribe to get exclusive updates